Unidentified non-neuronal targets

Unidentified non-neuronal targets is a placeholder designation used in pharmacological research and databases to describe biological sites of action located outside the nervous system that have not yet been molecularly characterized. This term is typically applied when a drug or compound demonstrates a clear physiological effect or binding affinity in peripheral tissues, but the specific receptor, enzyme, or transporter responsible for the activity remains unknown (ChEMBL Database). Because these targets lack a defined molecular structure or genetic sequence, they cannot be utilized for rational drug design or targeted therapy development. The presence of such unidentified targets in a drug's profile often suggests a risk of polypharmacology and unpredictable off-target effects, which can complicate safety evaluations and clinical progression. In modern drug discovery, identifying these specific proteins through techniques like proteomics or affinity chromatography is a high priority to transition from phenotypic observations to target-based precision medicine. Consequently, this entry does not represent a single therapeutic target but rather a gap in current biological knowledge.

Other names

Unknown non-neuronal binding sitesUncharacterized peripheral targetsNon-specific non-neuronal targets

The mechanism of action is unknown as the specific molecular entities have not been identified.